Negative pressure wound therapy is a concept introduced initially to assist in the treatment of chronic open wounds. Recently, there has been growing interest in using the technique on closed incisions after surgery to prevent potentially severe surgical site infections and other wound complications in high-risk patients. Negative pressure wound therapy uses a negative pressure unit and specific dressings that help to hold the incision edges together, redistribute lateral tension, reduce edema, stimulate perfusion, and protect the surgical site from external infectious sources. Randomized, controlled studies of negative pressure wound therapy for closed incisions in orthopedic settings (which also is a clean surgical procedure in absence of an open fracture) have shown the technology can reduce the risk of wound infection, wound dehiscence, and seroma, and there is accumulating evidence that it also improves wound outcomes after cardiothoracic surgery. Identifying at-risk individuals for whom prophylactic use of negative pressure wound therapy would be most cost-effective remains a challenge; however, several risk-stratification systems have been proposed and should be evaluated more fully. The recent availability of a single-use, closed incision management system offers surgeons a convenient and practical means of delivering negative pressure wound therapy to their high-risk patients, with excellent wound outcomes reported to date. Although larger, randomized, controlled studies will help to clarify the precise role and benefits of such a system in cardiothoracic surgery, limited initial evidence from clinical studies and from the authors' own experiences appears promising. In light of the growing interest in this technology among cardiothoracic surgeons, a consensus meeting, which was attended by a group of international experts, was held to review existing evidence for negative pressure wound therapy in the prevention of wound complications after surgery and to provide recommendations on the optimal use of negative pressure wound therapy on closed median sternal incisions after cardiothoracic surgery.
Background
Surgical site infections (SSIs) are serious complications after cardiothoracic surgery and contribute significantly to post-operative morbidity, mortality, and healthcare costs [1] [2] [3] . Studies have reported that up to 15% of patients develop a wound infection after cardiac surgery [4] [5] [6] [7] ; with rates of SSIs ranging from 0.5 to 22.2% [8] [9] [10] [11] [12] [13] [14] . Incidence rates for deep sternal wound infection (DSWI) have ranged from 0.4 to 2.6%, with mortality rates of between 7 and 35% reported with conventional therapies such as surgical revision with open packing dressing, rewiring over a surgical drain(s), or reconstruction with vascularized soft tissue flaps compared with only 2.7-7.1% in uninfected controls [2, 6, 11, [15] [16] [17] [18] [19] [20] [21] [22] [23] . Mortality rates are especially high (up to 74%) in patients with DSWI due to methicillin-resistant Staphylococcus aureus (MRSA) [24, 25] .
Host factors contributing to the risk of SSIs after cardiothoracic surgery have been well described in the literature and include obesity, renal insufficiency, diabetes mellitus, advanced age, gender, chronic obstructive pulmonary disease, smoking, steroid use, and length of hospitalization (>5 days) [1, 19, 22, 23, 26] . Surgical risk factors include the use of 1 or 2 internal mammary artery (IMA) grafts (especially bilaterally and when using the pedicle IMA), duration of surgery and perfusion time, prolonged mechanical ventilation, use of an intra-aortic balloon pump, post-operative bleeding, re-operation, sternal rewiring, extensive electro-cautery, shaving with razors, and use of bone wax [1, 23] .
Surgical incisional wounds have traditionally been closed by primary intention using sutures, staples, or a combination of these methods. After closure of clean surgical incisions, wound care may include the use of traditional gauze dressings, and more advanced therapies such as hydrocolloids, growth factors, cultured skin, low-energy ultrasound, and negative pressure wound therapy (NPWT) (V.A.C. ® Therapy, Kinetic Concepts, Inc., San Antonio, TX, USA).
NPWT is a treatment concept introduced initially to assist in the treatment of acute and chronic open wounds [27, 28] . NPWT uses a negative-pressure device and specific dressings to create a negative-pressure environment at the wound site. This helps to hold the incision edges together [29] , reduces lateral tension and edema [30, 31] , stimulates perfusion [27, [32] [33] [34] [35] [36] , enhances the development of granulation tissue [27, 37, 38] , reduces bacterial colonization of wound tissues [27, 39] , and protects the surgical site from external infectious sources [40] .
NPWT has also become a well-established method for improving outcomes after skin grafting, where the technique is used to prepare the wound surface for graft acceptance and to stabilize the graft to prevent shearing and removal [41] [42] [43] .
In this clinical setting, removal of exudate reduces the risk of hematoma and seroma formation and helps to prevent contamination [44] . Increased granulation facilitates revascularization and attachment of the graft to the wound bed [45] . Numerous clinical studies have shown the successful use of NPWT in the management of both skin and biomatrix grafts (reviewed by Gupta in 2012) [45] .
Recently, there has been growing interest in using the technique on closed incisions to prevent potentially severe SSIs and other wound complications in high-risk individuals. This paper aims to review existing evidence for NPWT in the prevention of wound complications after surgery and to provide consensus recommendations on optimizing the use of NPWT after cardiothoracic procedures. The paper has been developed from a consensus meeting held in Amsterdam in November 2011.
NPWT for Prevention of Wound Complications: Clinical Evidence
Randomized controlled trials (RCTs), retrospective studies, and case series provide a substantial body of evidence that the use of either NPWT or closed incision management (CIM; Prevena™ Therapy [Kinetic Concepts, Inc., San Antonio, TX, USA]) (Figure 1 ) may reduce the incidence of wound infections and other wound complications in a variety of post-surgical wound types (Table 1) [28, [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] . Orthopedic studies were included as well as cardiac surgery, because both are considered to be clean surgery [54] . In case of infection, the (Figure 2 ). The relative risk of developing an infection was 1.9 times higher in control patients than in those treated with NPWT (95% confidence interval, 1.03-3.55). A significant reduction in the risk of wound dehiscence after discharge was also observed in the NPWT group (8.6% of fractures) versus the control group (16.5% of fractures) (p<0.044).
NPWT was applied for a mean of 2.5 days (range, <1-9.0 days) in this study, and these patients were ready for hospital discharge half a day earlier than patients in the control group (not statistically significant), which more than offset the cost of the NPWT. The investigators concluded that, based on the results of the study, prophylactic application of NPWT to highrisk wounds before their failure appeared to be an efficacious treatment strategy. These findings confirm earlier reports of 2 small, randomized controlled trials of NPWT in trauma patients, in which NPWT was associated with decreased draining from surgical incisions and improved wound healing [52] .
Pachowsky et al. (2012) conducted a prospective, randomized evaluation of NPWT using CIM after total hip arthroplasty [49] . In the study, 19 patients were randomized to receive either standard dry wound dressings (control group; n=10) or CIM (n=9) over the sutured wound area. All patients received 2 Redon drains: 1 in the deep areas of the wound close to the prosthesis and 1 above the closed fascia. Ultrasound examination on Day 10 post-surgery revealed that 90% of patients in the control group and 44% of the patients in the NPWT group had developed a seroma. The average seroma volume was 5.08±5.11 mL in the control group compared with only 1.97±3.21 mL in the NPWT group (p=0.021). The control group received antibiotics for a mean of 11.8±2.8 days compared with 8.4±2.2 days in the NPWT group (p=0.005).
Retrospective studies [50, 51] and case series [49] suggest similar benefits of NPWT in terms of a low incidence of infections and other complications after orthopedic surgery.
Evidence for the benefits of NPWT in preventing wound complications after cardiothoracic surgery has accumulated through published retrospective chart review studies [46, 57] and case studies [28, 47] .
Grauhan et al. [56] Atkins et al. (2009) reported on 57 adult cardiac surgery patients who had received NPWT (mainly clean, closed median sternotomy incision) because they were considered to be at increased risk of sternal wound infection (SWI) and other wound healing complications [46] . At completion of the cardiac surgical procedure, the sternotomy incision was closed as per routine practice. A single layer of non-adhesive gauze was placed over the clean, closed incision followed by a thin strip (1.0-1.5 cm) of silver-impregnated foam (V.A.C. GRANUFOAM SILVER ® DRESSING, Kinetic Concepts, Inc., San Antonio, TX, USA).
An occlusive transparent dressing was placed over the foam, and negative pressure was applied to the foam through an incision in the drape via a pressure-sensing pad (T.R.A.C. ™ Pad, Kinetic Concepts, Inc., San Antonio, TX, USA) with tubing connected to the therapy unit (V.A.C. ® Therapy, Kinetic Concepts, Inc., San Antonio, TX, USA), thereby creating the environment for NPWT. Therapy was continued for 4 days post-operatively.
Of the 57 NPWT-treated patients, 77.2% were obese, 54.4% were diabetic, and 50.9% were obese and diabetic. Overall, 50.9% of the NPWT-treated patients underwent coronary artery bypass graft (CABG) with 1 internal mammary artery, almost 20% underwent concomitant CABG and other cardiac procedures such as valvular heart surgery or atrial maze procedure, and 14% underwent CABG with bilateral mammary artery use. NPWT was well tolerated by all patients until completion, and no recordable amount of exudate wound fluid was reported in any patient. The estimated risk for post-operative DSWI was based on risk scores developed by Fowler et al. in 2005 [14] . This scoring system assigns points for individual pre-operative and intra-operative risk factors for major postoperative infection, enabling a probability of infection (%) to be estimated [13] . Based on this system, the estimated average risk for developing post-operative DSWI in this group of high-risk surgical patients was 6.1±4.0%; therefore, at least 3 cases of DSWI were anticipated in this series of 57 patients. Ten patients (17.5%) required readmission within the first 30 days after discharge; however, no admissions were due to sternal wound complications (Table 2 ) [45] . In this population of high-risk patients treated with NPWT, there were no reports of DSWI or superficial SWI, leading the authors to recommend that NPWT should be strongly considered for patients with increased risk of SWI. No data relating to a 1-year follow-up of these patients were reported in the paper.
More recent evidence comes from Colli, who used CIM over the surgical incisions in a small prospective cohort study of 10 patients at high risk for SWI (Fowler risk score, 8-30 ) following CABG surgery [47] . All 10 patients received CIM for 5 continuous days immediately following standard wound closure. Wounds and surrounding skin were inspected following removal of the CIM dressing and at Day 30 after surgery. The system was well tolerated and all patients experienced complete wound healing with no evidence of early or late wound infections.
These preliminary findings demonstrate the favorable efficacy and safety of CIM in preventing wound complications after cardiac surgery; however, larger, randomized controlled trials are warranted to more clearly define the patient population and wound types that would benefit most from this type of therapy. Whether CIM will be able to prevent sternal dehiscence or DSWI with sternal involvement remains a key issue, but according to current clinical evidence, the benefits of the system in terms of promoting skin healing may help to impede dehiscence and/or the development of DSWI. Indeed, most recent findings from a prospective study indicated that NPWT may prevent post-operative wound infections [56] .
Consensus statement
• Based on current published evidence, NPWT appears to effectively prevent wound complications when used over clean, closed surgical incisions, including median sternal incisions.
Modern Approaches to Applying NPWT/CIM
NPWT systems have evolved substantially in recent years and are now available as single-use devices designed specifically for the management of closed incisions in patients at risk of post-operative wound complications. The CIM device used in the studies by Colli (2011) [47] and Pachowsky et al. (2012) [49] consists of a single-use (i.e., completely disposable) NPWT unit, canister, and dressing that are designed for application over clean, closed, sutured, or stapled incisions in a simple peel-and-place process. The dressing is a polyurethane film with acrylic adhesive that adheres the dressing to the skin surrounding the incision and a polyurethane shell that encapsulates the foam bolster and interface layer, providing a closed system. The dressing has a built-in pressure indicator and a skin interface layer containing 0.019% ionic silver, which wicks fluid from the skin surface and reduces bacterial colonization within the fabric. The single-use, battery-powered therapy unit delivers negative pressure in the system at between -75 and -125 mmHg. The system also contains a sterile 45-mL canister for collection of incision exudate and additional drape patch strips that may be used to help seal leaks around the dressing.
Consensus recommendation
• Single-use devices such as CIM are recommended for the management of closed incisions in patients at high risk of post-operative wound complications.
Using NPWT in Cardiothoracic Surgery: Selecting Appropriate Patients
Prevention of surgical site infections remains a pressing concern to all healthcare professionals, and relies on the use of strict pre-, intra-, and post-operative infection control measures to optimize the patient's condition and to minimize contamination risk [57, 58] . Appropriate choice of incisional wound dressing and treatment, which are integral to most infection control guidelines, will depend on local preferences and availability, but should always be based on robust costeffectiveness evidence.
NPWT is an advanced technology that, based on data from a randomized controlled trial by Stannard et al. [53] , has been shown to be a cost-effective option when used for the prevention of wound infection and dehiscence in high-risk patients. However, questions remain over the best way to define highrisk patients in clinical practice.
In the studies by Atkins et al. (2009) [46] and Colli (2011) [47] , the risk of DSWI was assessed using the Fowler system [13] . According to this system, the use of both internal mammary arteries is assumed to double the risk of surgical wound infection, based on a previous evaluation of DSWI in this setting [60] . Additionally, a distinction is made between obese individuals with a body mass index (BMI) of 30-40 kg/m 2 and those with a BMI >40 kg/m 2 , with increased risk of surgical wound infection assigned to the latter category.
Stannard et al. (2009) proposed a simpler universal patient grading system to help determine which closed surgical incisions may be best suited for NPWT (Figure 3 ) [29] . Under this system, Grade 1 patients have linear or semi-linear wounds and no pre-existing medical conditions and are considered at low or no risk of developing post-surgical wound complications such as infection, seroma, hematoma, or dehiscence. Grade 2 patients have linear or semi-linear wounds and at least 1 moderate-to high-risk factor (diabetes, obesity, smoking, hypertension, steroid use, or radiation exposure), making them candidates for post-surgical NPWT. Grade 3 patients have linear, semi-linear, or complex wounds with undermining and 1 or more risk factors and may, therefore, benefit most from prophylactic use of incisional NPWT.
We believe that risk factors for major infections after cardiothoracic surgery can be divided into 3 categories: major, intermediate, and minor ( 
Consensus recommendations
• CIM should be considered for use in all high-or at-risk patients, regardless of skin type, with the aim of preventing wound infection and dehiscence after surgery.
• Selection of high-risk patients for post-operative use of NPWT should be based on a careful assessment of pre-operative risk factors. • Patients with 1 or more major risk factors (BMI <18 or ≥40 kg/m 2 , insulin-dependent diabetes mellitus, or dialysis treatment for chronic kidney disease) are strong candidates for prophylactic use of NPWT.
• Patients with 2 or more intermediate (or major) risk factors (e.g., use of bilateral mammary arteries, diabetes mellitus, chronic lung disease, or receiving long-term immunosuppressive medication) may also benefit from post-operative NPWT.
• We strongly recommend using CIM in heart, lung, and heart/ lung transplantation patients in view of the high degree of immunosuppression required; however, sternum stability is vital.
Optimizing the use of NPWT in Cardiothoracic Surgery
The authors of this consensus document have considerable experience in using the CIM for the prevention of wound complications after cardiothoracic surgery and have found the system to be easy to use and well tolerated by patients. The system should be applied immediately after surgery, in a sterile field (while the patient is still in the operating room and before the sterile drapes have been removed), to clean, closed incisions for a period of 5-7 days. When used preventively, the system should ideally be left undisturbed for at least 5 days, unless the patient develops clear signs of wound infection, such as pain. If the dressing is lifted to observe the incision, a new dressing should be applied.
If the wound extends beyond the length of the dressing, the dressing can be applied over part of the incision. It should not be placed over drains or wires, should not be used to treat open or dehisced surgical incisions, and should not be used in patients with sensitivity to silver.
Grade 1
Patient grading system Clean, closed, surgical wounds * No pre-wxisting medical conditions ** Know risk factors: diabetes, obesity, smoker, hypertension, steroid use, radiation, peripheral disease, etc. Skin preparation should include the use of chlorhexidine, iodine, or alcohol, with careful drying to prevent foil blistering. Drains should be placed in a lower position when planning to use CIM (see case studies).
Adapted from Stannard 2009
The system should be removed carefully with the vacuum turned off. Adequate closure of the wound, no redness at the incision site, and no evidence of edema upon dressing removal suggest that the wound has healed adequately. In our experience, concerns regarding the canister becoming too full of fluid are unfounded. A summary of consensus recommendations for optimizing the use of CIM after cardiothoracic surgery is presented in Table 4 .
Case Studies
The 3 case studies presented here show examples of the prophylactic use of NPWT over clean, closed surgical incisions after cardiothoracic surgery.
Case study 1: Urgent triple CABG and mitral valve replacement (MVR) via sternotomy
A 70-year-old male presented with a non-ST elevation myocardial infarction (Figure 4 ). His medical history included type 2 diabetes, peripheral vascular disease, renal insufficiency, hyperlipidemia, and pulmonary hypertension. The patient was diagnosed with triple vessel coronary artery disease and severe mitral insufficiency. Urgent triple CABG and MVR were performed. Due to his elevated risk of post-operative incision complications, the CIM system was used, with the dressing applied along the incision ( Figure 4A) , with special care taken to leave sufficient distance between the inferior aspect of the incision and the chest tubes in order to secure an adequate seal ( Figure 4B ). On post-operative day 3, the patient experienced a cardiopulmonary arrest requiring immediate resuscitative chest compressions. However, the integrity of CIM dressing was maintained.
Goal of treatment
• Prevention of wound infection and dehiscence in all at-risk patients
Appropriate patients • All heart, lung and heart/lung transplantation patients • All patients with major or multiple intermediate risk factors (see Table 3 On post-operative day 8, the CIM dressing was removed. The incision edges appeared well apposed and were healing appropriately ( Figure 4C ). In contrast, the chest tube sites, which were not treated with CIM, demonstrated some drainage. The patient was discharged home on post-operative day 18, with his incision continuing to heal well.
Case study 2: CABG and MVR via sternotomy
A 65-year-old male presented with progressive angina and a positive exertional stress test ( Figure 5 ). His medical history included diabetes mellitus, obesity (BMI 38 kg/m 2 ), and chronic obstructive pulmonary disease. Cardiac catheterization demonstrated severe 3-vessel coronary artery disease.
Four-vessel CABG was performed using left IMA to left anterior descending coronary artery and reverse saphenous vein grafts to the right coronary artery, ramus intermedius artery, and first diagonal artery, separately. The standard median sternal incision was approximately 10 inches in length. Sternal reapproximation was performed with stainless steel cables and the skin was closed with subcuticular sutures. The CIM dressing was applied in the operating theater and remained in place until it was removed on post-operative day 5.The patient was discharged on post-operative day 6. Revascularization was achieved using bilateral internal mammary grafting, as the saphenous vein and the radial artery were both unusable. Transdermal stitches were used to close the incision. The CIM system was selected prior to surgery, allowing the drains to be placed in a low position in order to accommodate both the dressing and the short stature of the patient. The CIM dressing was applied carefully, under sterile conditions, along the incision and left undisturbed for 5 days.
The dressing was removed on post-operative day 6; there was no edema or infection present, and the wound was healing well. The patient was discharged on post-operative day 10, with no surgical wound infection, even at the 30-day follow-up.
To date, the CIM system has been used successfully on 32 of the contributing author's (AM) patients with no signs of surgical wound infection during hospitalization or at the 30-day follow-up.
Summary and Conclusions
There is growing interest in the use of NPWT on closed incisions after cardiothoracic surgery to prevent potentially severe SSIs in high-risk individuals. Use of NPWT on closed incisions has been shown to reduce the risk of wound infection, wound dehiscence, and seroma in randomized, controlled studies of patients in orthopedic settings [47, 51] . NPWT also enhances graft adherence and survival after skin and biomatrix grafting [43] .
Evidence is now accumulating that NPWT improves wound outcomes after cardiothoracic procedures [28, 44, 45] . Based on published data and clinical evidence, we recommend that NPWT should be considered in at-risk patients with the aim of preventing DSWI after surgery.
Identifying at-risk individuals for whom prophylactic use of NPWT would be most cost-effective remains a challenge. However, several risk-stratification systems have been proposed [13, 28] , and should be evaluated more fully. In the meantime, we believe that patients with 1 or more major risk factors or multiple intermediate risk factors are strong candidates for prophylactic use of NPWT, and that any patient undergoing heart, lung, or heart/lung transplantation should receive this treatment.
The availability of the peel-and-place, single-use CIM system offers surgeons a convenient and practical solution to overcome SSIs in high-risk patients, and CIM is recommended by the authors based on their own clinical experiences. Larger, randomized studies will help to clarify the precise role and benefits of NPWT on closed incisions after cardiothoracic surgery; however, initial data appear very promising.
